Literature DB >> 8636531

The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock.

I Salvo1, W de Cian, M Musicco, M Langer, R Piadena, A Wolfler, C Montani, E Magni.   

Abstract

This prospective, multicenter, epidemiological study was carried out in 99 Italian ICUs, distributed throughout the country, from April 1993 to March 1994. In the study, we applied the new ACCP/SCCM classification system for sepsis (SIRS, sepsis, severe sepsis and septic shock) and determined the prevalence, incidence, evolution and outcome of these categories in critically ill patients. The preliminary analysis of 1101 patients showed that on admission SIRS accounted for about half of the diagnoses (52%) with sepsis, severe sepsis and septic shock accounting for 4.5%, 2.1% and 3% of patients, respectively. Patients with severe sepsis or septic shock more frequently had high SAPS scores than patients without sepsis. Mortality rates were similar in patients with SIRS (26.5%) and without SIRS or infection (24%), but rose to 36% in patients with sepsis, to 52% in those with severe sepsis and to 81.8% in those with septic shock. Sepsis, severe sepsis and septic shock were more common in patients with medical diagnoses, and neither severe sepsis nor septic shock was observed in trauma patients. With respect to evolution, the incidence of septic shock was progressively higher in patients admitted with more severe "sepsis-related" diagnoses, while only a trivial difference in rates of incidence was observed between SIRS patients and those admitted without SIRS or any septic disorder (nil). The breakdown of the various ACCP/SCCM "sepsis-related" diagnoses at any time during the study was: SIRS in 58% of the population, sepsis in 16.3%, severe sepsis in 5.5% and septic shock in 6.1%. It seems reasonable to expect from the final evaluation of our study answers to the questions raised by the ACCP/SCCM Consensus Conference about the correlations between "sepsis-related" diagnosis, severity score, organ dysfunction score and outcome.

Entities:  

Mesh:

Year:  1995        PMID: 8636531     DOI: 10.1007/bf01740762

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  13 in total

1.  Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

Review 2.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

Review 3.  Pathogenetic mechanisms of septic shock.

Authors:  J E Parrillo
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

Review 4.  The problem of sepsis. An expert report of the European Society of Intensive Care Medicine.

Authors: 
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

5.  Evaluation of definitions for sepsis.

Authors:  W A Knaus; X Sun; O Nystrom; D P Wagner
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

6.  Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group.

Authors:  C J Fisher; S M Opal; J F Dhainaut; S Stephens; J L Zimmerman; P Nightingale; S J Harris; R M Schein; E A Panacek; J L Vincent
Journal:  Crit Care Med       Date:  1993-03       Impact factor: 7.598

7.  Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial.

Authors:  C J Fisher; G J Slotman; S M Opal; J P Pribble; R C Bone; G Emmanuel; D Ng; D C Bloedow; M A Catalano
Journal:  Crit Care Med       Date:  1994-01       Impact factor: 7.598

Review 8.  The pathogenesis of sepsis.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

9.  A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.

Authors:  R L Greenman; R M Schein; M A Martin; R P Wenzel; N R MacIntyre; G Emmanuel; H Chmel; R B Kohler; M McCarthy; J Plouffe
Journal:  JAMA       Date:  1991-08-28       Impact factor: 56.272

10.  Multiple-organ failure. Generalized autodestructive inflammation?

Authors:  R J Goris; T P te Boekhorst; J K Nuytinck; J S Gimbrère
Journal:  Arch Surg       Date:  1985-10
View more
  46 in total

1.  Rapid detection of sepsis complicating acute necrotizing pancreatitis using polymerase chain reaction.

Authors:  W Z Zhang; T Q Han; Y Q Tang; S D Zhang
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Prevalence of infections and systemic inflammatory response syndrome in southern Spanish ICUs.

Authors:  R Sierra-Camerino; C Ortiz
Journal:  Intensive Care Med       Date:  2001-04       Impact factor: 17.440

Review 3.  [Surgical concepts for treatment of severe sepsis].

Authors:  O Kollmar; M K Schilling
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

4.  Determining disease severity in severe sepsis and septic shock.

Authors:  Michael W Donnino; Jonathan Fisher; Jonathan Fischer
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

5.  Incidence of sepsis in hospitalized patients.

Authors:  Rui Moreno; Susana Afonso; Teresa Fevereiro
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

Review 6.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Manu Shankar-Hari; Gary S Phillips; Mitchell L Levy; Christopher W Seymour; Vincent X Liu; Clifford S Deutschman; Derek C Angus; Gordon D Rubenfeld; Mervyn Singer
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

7.  9th European Congress on Intensive Care Medicine. Glasgow, United Kingdom, 24-28 September 1996. Abstracts.

Authors: 
Journal:  Intensive Care Med       Date:  1996       Impact factor: 17.440

Review 8.  Improving the Recognition of, and Response to In-Hospital Sepsis.

Authors:  Peter Chan; Sandra Peake; Rinaldo Bellomo; Daryl Jones
Journal:  Curr Infect Dis Rep       Date:  2016-07       Impact factor: 3.725

9.  Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study.

Authors:  Jesús Blanco; Arturo Muriel-Bombín; Víctor Sagredo; Francisco Taboada; Francisco Gandía; Luís Tamayo; Javier Collado; Angel García-Labattut; Demetrio Carriedo; Manuel Valledor; Martín De Frutos; María-Jesús López; Ana Caballero; José Guerra; Braulio Alvarez; Agustín Mayo; Jesús Villar
Journal:  Crit Care       Date:  2008-12-17       Impact factor: 9.097

10.  Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies.

Authors:  Laith Altaweel; Daniel Sweeney; Xizhong Cui; Amisha Barochia; Charles Natanson; Peter Q Eichacker
Journal:  Biologics       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.